Danaher (DHR)
(Delayed Data from NYSE)
$272.47 USD
-3.56 (-1.29%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $272.59 +0.12 (0.04%) 6:28 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Danaher Corporation [DHR]
Reports for Purchase
Showing records 21 - 40 ( 508 total )
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 2124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 11124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 1124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Life Science Tools - ALERT: Implications of LLY Receiving FDA Approval for Zepbound
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
3Q23 Earnings and Prudent Guide Seems Like Good Setup
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 102123
Provider: Stock Traders Daily
Analyst: Research Department